A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323
Clinical trial NCT02094924 · COMPLETED
Trial details
- NCT number
- NCT02094924
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-17
- Primary completion
- 2014-05-23
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.